Are Adults’ Eczema Rates Rising With Climate Change? Docwire News Source link
Nektar Jumps 157% on Drug Trial Data—Can It Go Even Higher? MarketBeat Source link
Previewing the 2025 SDPA Annual Summer Dermatology Conference: What to Expect Dermatology Times Source link
Nektar Declares Phase IIb Eczema Win for Rezpeg—But Analysts Unconvinced BioSpace Source link